合富中国 (603122)

Cowealth Medical China Co., Ltd.

ASH

Tags

AI HealthcareArtificial Intelligence (AI)New Insurance HoldingsPharmaceuticals and HealthcarePharmaceutical CommerceWholesaleYesterday's Continuously Limit-Up StocksYesterday's High TurnoverSmart HealthcareWest Coast of the Taiwan StraitTongdaxin Hot Stocks

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 39805.26
  • Circulating A-Shares(W): 39805.26
  • Earnings Per Share(RMB): -0.03
  • Net Assets Per Share(RMB): 2.78
  • Operating Revenue(W RMB): 54886.23
  • Total Profit(W RMB): -1459.45
  • **Net Profit Attributable to Parent(W RMB) **: -1238.62
  • Net Profit Growth Rate(%): -146.65
  • Weighted Return on Equity(%): -1.06
  • Operating Cash Flow Per Share(RMB): 0.26
  • Undistributed Profit Per Share(RMB): 0.16
  • Capital Reserve Per Share(RMB): 1.50

2. Main Business

The main business covers:

  • Distributor in the medical circulation field

3. Company Basic Information

  • Company Name: Cowealth (China) Medical Technology Co., Ltd.
  • Listing Date: 2022-02-16
  • Industry: Wholesale Trade
  • Address: Guangqi Building, No. 456 Hongcao Road, Xuhui District, Shanghai
  • Website: https://www.cowealth.com
  • Company Profile: The company was established by the overall transformation of Cowealth Limited into a joint stock company. On March 18, 2019, the board of Cowealth Limited resolved to approve the overall transformation into a foreign-invested joint stock company as of the base date of January 31, 2019. The audited net assets of Cowealth Limited as of January 31, 2019, totaling RMB 336,001,547.75, were converted into 212,015,683 shares at a ratio of 1:0.6310. The remaining RMB 123,985,864.75 was recorded into the company's capital reserve. After the股份制改造, the name was changed to Cowealth (China) Medical Technology Co., Ltd. On the same day, Cowealth Hong Kong, Quezi Limited, Yuancheng Partnership, Yuanang Partnership, Yuanyi Partnership, Yuanyu Partnership, and Huajin Limited signed the "Sponsor Agreement for the Overall Transformation of Cowealth (China) Medical Technology Trade Co., Ltd. into a Foreign-invested Joint Stock Company." On March 22, 2019, all sponsors held the founding meeting and the first interim shareholders' meeting of 2019, reviewing and approving the relevant proposals for the overall transformation. On March 29, 2019, the China (Shanghai) Pilot Free Trade Zone Management Committee issued the "Foreign-invested Enterprise Change Filing Receipt" (No. BSQ201901050). On April 19, 2019, the Shanghai Municipal Administration for Market Regulation reissued the "Business License" (Unified Social Credit Code: 91310000703011187G). On April 22, 2019, according to the "Capital Verification Report" (Shang Hui Shi Bao Zi [2019] No. 3878) issued by Shanghui Certified Public Accountants, as of April 19, 2019, the issuer had converted the audited net assets of Cowealth Limited as of January 31, 2019 into a total of 212,015,683 shares, with a total share capital of RMB 212,015,683.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Cowealth (Hong Kong) Holding Co., Ltd. General Legal Person 21893.79 55.00
2 Quezi Limited General Legal Person 212.67 0.53
3 Lianfang Limited General Legal Person 122.84 0.31
4 Shanghai Yuanyu Enterprise Management Consulting Center (Limited Partnership) General Legal Person 84.71 0.21
5 Ping An Life Insurance Company of China, Ltd. - New Dividend Policy No. 8 - Mandate (Bank of Communications) Insurance 76.31 0.19

5. Concept Sectors

  • Smart Healthcare
  • Artificial Intelligence
  • AI in Healthcare

Remarks

  • Data update date: 2025-09-30
  • Data source: Public Market Information